Efficacy of Co- enzyme Q-10 in pneumonia

Not Applicable

• Conditions: Bacterial pneumonia, not elsewhere classified; Condition 1: community acqured pnemonia. Condition 2: community acqured pnemonia. Condition 3: community acqured pnemonia.; Pneumonia due to Streptococcus pneumoniae; Pneumonia due to Haemophilus influenzae

• Registration Number: IRCT201305159855N3
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

inclusion criteria : age=65; Community acquired pneumonia patients
exclusin criteria : the age of less than 65 years ; hemodynamic instability ; chronic liver failure; chronic heart failure; chronic renal failure ; Co- enzyme Q-10 consumption during 1 month before arrival to study; history of allergic reactions; receiving the drugs or compounds with antioxidant effect such as vitamin C; vitamin E or vitamin A; HIV patients

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical Signs and Symptoms(Temprature,Respiratory rate,Pulse rate,Blood pressure,Dyspnea,Sputum production,Crackle and rale). Timepoint: 0,3,7,14. Method of measurement: Physical examination based on quastionair.

Secondary Outcome Measures

Name	Time	Method
Decrease of leukocyte count. Timepoint: 0,3,7,14. Method of measurement: Complet blood count.;Decrease of CRP and ESR. Timepoint: 0,3,7,14. Method of measurement: Check of ESR and CRP.;Blood O2 Saturation. Timepoint: 0,3,7,14. Method of measurement: Check of blood O2.